Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

May 31, 2016

Conditions
Opioid-Related DisordersNeuralgia
Interventions
DRUG

Dexmedetomidine

The participants will be given infusion of dexmedetomidine 0,5 mcg/kg/h intravenously.

DRUG

Lidocaine

The participants will be given infusion of lidocaine 1,5 mg/kg/h intravenously.

OTHER

placebo

The participants will be given infusion of normal saline intravenously.

DRUG

Fentanyl

Fentanyl 2 mcg/kg will be given to all participants for the intubation and during the operation when ANI value drops below 50.

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT02616523 - Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection | Biotech Hunter | Biotech Hunter